Latest Stock Market News

Infosys had spent between Rs 8,000-9,000 crores in the last two share buybacks, and some analysts feel that the buyback size this time could be bigger. According to IIFL Securities, the IT major could announce a buyback size of Rs 11,000-12,000 crores.

US stocks open lower on earnings anxiety

Updated at : 2022-10-11 21:20:01

Rate this item

(1 Vote)

The Dow Jones Industrial Average fell 117.68 points, or 0.40%, at the open to 29,085.20. The S&P 500 opened lower by 16.53 points, or 0.46%, at 3,595.86, while the Nasdaq Composite dropped 57.73 points, or 0.55%, to 10,484.37 at the opening bell.

Rate this item

(1 Vote)

As per the shareholding pattern of the company for the September quarter, Brightstar Investor does not find a mention in the list of public shareholders for 3M India. However, in the June quarter, the firm held 1,66,700 shares, equivalent to a 1.48% stake in the company.

"I am hopeful that the real estate sector will start doing better. The affordability index, despite high interest rates, is quite low and that is the starting point for most real estate companies when it comes to booking their sales"

DCM Shriram fixes record date for interim dividend

Updated at : 2022-10-11 21:20:01

Rate this item

(1 Vote)

In an exchange filing, the company informed about the meeting of the board of directors scheduled for Wednesday, 19th October, for considering the unaudited financial results (both Standalone and Consolidated) for September and also the payment of interim dividend, if any, for the financial year 2022-23.

The regulator also noted that there were nine complaints as of September this year which were pending for more than three months pertaining to investment adviser, research analyst, non-demat, remat, refunds, dividends and rights, among others.

Rate this item

(1 Vote)

In its commentary after announcing the second quarter results on Monday, the company flagged concerns about the global economy, saying things are challenging and that it will stay vigilant to minimise the impact of the overall market on its business.

"Pharma companies which have domestic as well as export markets can be good to invest in at a high price"

For more such web stories click on the ET icon below

At a time when global central banks are constrained by unanchored inflation and are forced to remain on the tightening path, growth slowdown concerns have pulled down commodity prices.

Warning! Information Posting in this website is only for educational purpose. We are not responsible for losses incurred in Trading based on this information.